Eidogen-Sertanty Licenses Software To Cephalon

San Diego-based Eidogen-Sertanty, a provider of computation drug discovery informatics software, said today that it has licensed its software and databases to Celphalon. The firm said that Cephalon will access its Kinase Knowledgebase, Target Informatics Platform, and EVE Comparitive Visualization software. Financial terms were not disclosed. Cephalon will use the software to support its small molecule drug discovery projects in neurology and oncology. Eidogen-Sertanty is backed by Tavistock Life Sciences.